The Dilemma of TP53 Codon 72 Polymorphism (rs1042522) and Breast Cancer Risk: A Case-Control Study and Meta-Analysis in The Iranian Population.

Conclusion: These findings cannot support contribution of rs1042522 polymorphism to breast cancer risk in an Iranian population. Future larger studies may help confirm this finding with a greater power. PMID: 31721533 [PubMed]

https://www.ncbi.nlm.nih.gov/pubmed/31721533?dopt=Abstract

Source: Cancer Control - November 15, 2019 Category: Cancer & Oncology Authors: Afzaljavan F, Chaeichi Tehrani N, Rivandi M, Zarif Ghasemian S, Vahednia E, Khayami R, Abavisani M, Pasdar A Tags: Cell J Source Type: research